Senior insider sale
Chief Discovery Officer at MAPLIGHT THERAPEUTICS, INC. — senior position signals high conviction
$1.44M
48.78K shares
KREITZER ANATOL plans to sell 48.78K shares of MAPLIGHT THERAPEUTICS, INC. valued at approximately $1.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted stock unit settlement
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/15/2026 | Restricted stock unit settlement N/A | 12.50K | — |
| Total | 12.50K | ||
Completed
Units to sell
2.83K
Market value
$105.0K
Units to sell
14.14K
Market value
$533.1K
Units to sell
200.00
Market value
$7.7K
Units to sell
7.46K
Market value
$273.6K
Units to sell
1.59K
Market value
$59.6K
Units to sell
5.54K
Market value
$200.3K
Units to sell
4.51K
Market value
$166.6K
Planned — Approximate Date
Units to sell
12.50K
Market value
$97.6K
Units
48.78K
Value
$1.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/17/2026 | 2.83K | $105.0K | — | Completed |
7/17/2026 | 14.14K | $533.1K | — | Completed |
7/17/2026 | 200.00 | $7.7K | — | Completed |
7/16/2026 | 7.46K | $273.6K | — | Completed |
7/16/2026 | 1.59K | $59.6K | — | Completed |
7/15/2026 | 5.54K | $200.3K | — | Completed |
7/15/2026 | 4.51K | $166.6K | — | Completed |
| Planned — Approximate Date | ||||
10/15/2026 | 12.50K | $97.6K | Nasdaq | Planned |
| Total | 48.78K | $1.44M | ||